206 related articles for article (PubMed ID: 38577372)
21. Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes.
Verma R; Chen S; Feldman R; Schieltz D; Yates J; Dohmen J; Deshaies RJ
Mol Biol Cell; 2000 Oct; 11(10):3425-39. PubMed ID: 11029046
[TBL] [Abstract][Full Text] [Related]
22. A proteomic analysis of p53-independent induction of apoptosis by bortezomib in 4T1 breast cancer cell line.
Yerlikaya A; Okur E; Baykal AT; Acılan C; Boyacı I; Ulukaya E
J Proteomics; 2015 Jan; 113():315-25. PubMed ID: 25305590
[TBL] [Abstract][Full Text] [Related]
23. The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment.
Zhang L; Wu M; Su R; Zhang D; Yang G
Recent Pat Anticancer Drug Discov; 2022; 17(3):268-283. PubMed ID: 34856915
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment.
Xu DC; Yang L; Zhang PQ; Yan D; Xue Q; Huang QT; Li XF; Hao YL; Tang DL; Ping Dou Q; Chen X; Liu JB
Acta Pharmacol Sin; 2022 Aug; 43(8):2128-2138. PubMed ID: 34893683
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of New Thiourea-Metal Complexes with Promising Anticancer Properties.
Canudo-Barreras G; Ortego L; Izaga A; Marzo I; Herrera RP; Gimeno MC
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833983
[TBL] [Abstract][Full Text] [Related]
26. Stress-induced polyubiquitination of proteasomal ubiquitin receptors targets the proteolytic complex for autophagic degradation.
Cohen-Kaplan V; Ciechanover A; Livneh I
Autophagy; 2017 Apr; 13(4):759-760. PubMed ID: 28121483
[TBL] [Abstract][Full Text] [Related]
27. The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells.
Schmidt M; Altdörfer V; Schnitte S; Fuchs AR; Kropp KN; Maurer S; Müller MR; Salih HR; Rittig SM; Grünebach F; Dörfel D
Neoplasia; 2019 Jul; 21(7):653-664. PubMed ID: 31132676
[TBL] [Abstract][Full Text] [Related]
28. 1 : 1 complexes of silver(I) thiocyanate with (substituted) thiourea ligands.
Bowmaker GA; Pakawatchai C; Saithong S; Skelton BW; White AH
Dalton Trans; 2009 Apr; (14):2588-98. PubMed ID: 19319404
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial Therapy by Ag
Jagusiak A; Gosiewski T; Romaniszyn D; Lasota M; Wiśniewska A; Chłopaś K; Ostrowska B; Kościk I; Bulanda M
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008445
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of neuronal 19S proteasome subunits induces the formation of ubiquitinated inclusions in the absence of cell death.
Droggiti A; Ho CC; Stefanis L; Dauer WT; Rideout HJ
J Neurochem; 2011 Nov; 119(3):630-43. PubMed ID: 21883213
[TBL] [Abstract][Full Text] [Related]
31. Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy.
Driscoll JJ; Dechowdhury R
Target Oncol; 2010 Dec; 5(4):281-9. PubMed ID: 21125340
[TBL] [Abstract][Full Text] [Related]
32. Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers.
Zhang X; Linder S; Bazzaro M
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272746
[TBL] [Abstract][Full Text] [Related]
33. L-Ornithine Schiff base-copper and -cadmium complexes as new proteasome inhibitors and apoptosis inducers in human cancer cells.
Zhang Z; Bi C; Fan Y; Zhang N; Deshmukh R; Yan X; Lv X; Zhang P; Zhang X; Dou QP
J Biol Inorg Chem; 2015 Jan; 20(1):109-121. PubMed ID: 25467055
[TBL] [Abstract][Full Text] [Related]
34. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials.
Nabavi SF; Atanasov AG; Khan H; Barreca D; Trombetta D; Testai L; Sureda A; Tejada S; Vacca RA; Pittalà V; Gulei D; Berindan-Neagoe I; Shirooie S; Nabavi SM
Cancer Lett; 2018 Oct; 434():101-113. PubMed ID: 30030139
[TBL] [Abstract][Full Text] [Related]
35. L-glutamine Schiff base copper complex as a proteasome inhibitor and an apoptosis inducer in human cancer cells.
Xiao Y; Bi C; Fan Y; Cui C; Zhang X; Dou QP
Int J Oncol; 2008 Nov; 33(5):1073-9. PubMed ID: 18949371
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity.
Arlt A; Sebens S; Krebs S; Geismann C; Grossmann M; Kruse ML; Schreiber S; Schäfer H
Oncogene; 2013 Oct; 32(40):4825-35. PubMed ID: 23108405
[TBL] [Abstract][Full Text] [Related]
37. Periodic DFT modeling and vibrational analysis of silver(I) cyanide complexes of thioureas.
Ahmad S; Georgieva I; Hanif M; Monim-Ul-Mehboob M; Munir S; Sohail A; Isab AA
J Mol Model; 2019 Mar; 25(4):90. PubMed ID: 30847580
[TBL] [Abstract][Full Text] [Related]
38. The cyclophilin-like domain of Ran-binding protein-2 modulates selectively the activity of the ubiquitin-proteasome system and protein biogenesis.
Yi H; Friedman JL; Ferreira PA
J Biol Chem; 2007 Nov; 282(48):34770-8. PubMed ID: 17911097
[TBL] [Abstract][Full Text] [Related]
39. Targeting the ubiquitin+proteasome system in solid tumors.
Driscoll JJ; Woodle ES
Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
[TBL] [Abstract][Full Text] [Related]
40. Interference with the 19S proteasomal regulatory complex subunit PSMD4 on the sperm surface inhibits sperm-zona pellucida penetration during porcine fertilization.
Yi YJ; Manandhar G; Sutovsky M; Zimmerman SW; Jonáková V; van Leeuwen FW; Oko R; Park CS; Sutovsky P
Cell Tissue Res; 2010 Aug; 341(2):325-40. PubMed ID: 20526895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
